{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:03:33Z","timestamp":1789502613081,"version":"build-2803163510"},"reference-count":200,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1005520"],"award-info":[{"award-number":["NRF-2021R1A2C1005520"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A6A1A03043708"],"award-info":[{"award-number":["NRF-2020R1A6A1A03043708"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Activation of microglia and\/or astrocytes often releases proinflammatory molecules as critical pathogenic mediators that can promote neuroinflammation and secondary brain damages in diverse diseases of the central nervous system (CNS). Therefore, controlling the activation of glial cells and their neuroinflammatory responses has been considered as a potential therapeutic strategy for treating neuroinflammatory diseases. Recently, receptor-mediated lysophospholipid signaling, sphingosine 1-phosphate (S1P) receptor- and lysophosphatidic acid (LPA) receptor-mediated signaling in particular, has drawn scientific interest because of its critical roles in pathogenies of diverse neurological diseases such as neuropathic pain, systemic sclerosis, spinal cord injury, multiple sclerosis, cerebral ischemia, traumatic brain injury, hypoxia, hydrocephalus, and neuropsychiatric disorders. Activation of microglia and\/or astrocytes is a common pathogenic event shared by most of these CNS disorders, indicating that lysophospholipid receptors could influence glial activation. In fact, many studies have reported that several S1P and LPA receptors can influence glial activation during the pathogenesis of cerebral ischemia and multiple sclerosis. This review aims to provide a comprehensive framework about the roles of S1P and LPA receptors in the activation of microglia and\/or astrocytes and their neuroinflammatory responses in CNS diseases.<\/jats:p>","DOI":"10.3390\/ijms22157864","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T10:31:44Z","timestamp":1627036304000},"page":"7864","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Critical Roles of Lysophospholipid Receptors in Activation of Neuroglia and Their Neuroinflammatory Responses"],"prefix":"10.3390","volume":"22","author":[{"given":"Bhakta Prasad","family":"Gaire","sequence":"first","affiliation":[{"name":"College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Yeonsu-gu, Incheon 21936, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Woong","family":"Choi","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Yeonsu-gu, Incheon 21936, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fncel.2017.00024","article-title":"Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation","volume":"11","author":"Jakel","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1126\/science.298.5593.556","article-title":"New insights into neuron-glia communication","volume":"298","author":"Fields","year":"2002","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2015.12.051","article-title":"Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish","volume":"1656","author":"Meyer","year":"2017","journal-title":"Brain Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuropharm.2016.04.026","article-title":"Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies","volume":"110","author":"Tognatta","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10571-017-0504-2","article-title":"Microglia: Housekeeper of the Central Nervous System","volume":"38","author":"Kabba","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/jpet.120.265058","article-title":"Microglia and Other Myeloid Cells in Central Nervous System Health and Disease","volume":"375","author":"Gopinath","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tins.2003.08.008","article-title":"New roles for astrocytes: Redefining the functional architecture of the brain","volume":"26","author":"Nedergaard","year":"2003","journal-title":"Trends Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cell.2015.08.029","article-title":"SnapShot: Astrocytes in Health and Disease","volume":"162","author":"Liddelow","year":"2015","journal-title":"Cell"},{"key":"ref_10","first-page":"151097","article-title":"The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: A brief review","volume":"2010","author":"Griffiths","year":"2010","journal-title":"Int. J. Inflam."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"671499","DOI":"10.3389\/fnagi.2021.671499","article-title":"The Role of Microglia in Perioperative Neuroinflammation and Neurocognitive Disorders","volume":"13","author":"Saxena","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature17623","article-title":"Astrocyte scar formation aids central nervous system axon regeneration","volume":"532","author":"Anderson","year":"2016","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/138161206775193109","article-title":"Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases","volume":"12","author":"Chun","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nri1650","article-title":"Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network","volume":"5","author":"Rosen","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1046\/j.1471-4159.1994.63051839.x","article-title":"Characterization of lysophospholipid metabolizing enzymes in human brain","volume":"63","author":"Ross","year":"1994","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbalip.2012.07.015","article-title":"Lysophospholipids and their receptors in the central nervous system","volume":"1831","author":"Choi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA receptors: Subtypes and biological actions","volume":"50","author":"Choi","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jop.2013.0194","article-title":"Bioactive lysophospholipids: Role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma","volume":"30","author":"Rao","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_20","first-page":"25","article-title":"Biological effects of lysophospholipids","volume":"160","author":"Rivera","year":"2008","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/ars.2017.7069","article-title":"Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury","volume":"28","author":"Shao","year":"2018","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/ten.teb.2015.0107","article-title":"Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering","volume":"21","author":"Binder","year":"2015","journal-title":"Tissue Eng. Part B Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101068","DOI":"10.1016\/j.plipres.2020.101068","article-title":"Emerging roles of lysophospholipids in health and disease","volume":"80","author":"Tan","year":"2020","journal-title":"Prog. Lipid. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnmol.2020.00058","article-title":"Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer\u2019s Disease: From Physiological Performance to Pathological Impairment","volume":"13","author":"Hao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-11-37","article-title":"Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes","volume":"11","author":"Crack","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.ajpath.2012.06.007","article-title":"Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes","volume":"181","author":"Goldshmit","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"492659","DOI":"10.1155\/2015\/492659","article-title":"Exogenous S1P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S1P Receptor Signaling","volume":"2015","author":"Moon","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1523\/JNEUROSCI.4703-14.2015","article-title":"Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury","volume":"35","author":"Hernandez","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1074\/jbc.M102691200","article-title":"Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells","volume":"276","author":"Moller","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/dvdy.23","article-title":"LPA1, LPA2, LPA4, and LPA6 receptor expression during mouse brain development","volume":"248","author":"Suckau","year":"2019","journal-title":"Dev. Dyn."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2020.05.068","article-title":"Differential anatomical and cellular expression of lysophosphatidic acid receptor 1 in adult mouse brain","volume":"531","author":"Kajitani","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/1389450116666151001112710","article-title":"Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems","volume":"17","author":"Healy","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12017-020-08614-2","article-title":"Sphingosine 1-Phosphate Receptors in Cerebral Ischemia","volume":"23","author":"Gaire","year":"2021","journal-title":"Neuromolecular Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/glia.23663","article-title":"Neural sphingosine 1-phosphate accumulation activates microglia and links impaired autophagy and inflammation","volume":"67","author":"Karunakaran","year":"2019","journal-title":"Glia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"118915","DOI":"10.1016\/j.bbamcr.2020.118915","article-title":"Sphingosine-1-phosphate induces migration of microglial cells via activation of volume-sensitive anion channels, ATP secretion and activation of purinergic receptors","volume":"1868","author":"Zahiri","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8841026","DOI":"10.1155\/2020\/8841026","article-title":"In Vitro Oxygen-Glucose Deprivation-Induced Stroke Models with Human Neuroblastoma Cell- and Induced Pluripotent Stem Cell-Derived Neurons","volume":"2020","author":"Juntunen","year":"2020","journal-title":"Stem. Cells Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-7526-6_18","article-title":"An In Vitro Oxygen-Glucose Deprivation Model for Studying Ischemia-Reperfusion Injury of Neuronal Cells","volume":"1717","author":"Ryou","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00011-016-0939-9","article-title":"Sphingosine kinase 1\/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia\/reperfusion","volume":"65","author":"Lv","year":"2016","journal-title":"Inflamm. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1471-4159.2007.04755.x","article-title":"Distribution of sphingosine kinase activity and mRNA in rodent brain","volume":"103","author":"Blondeau","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuroscience.2009.12.020","article-title":"Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia","volume":"166","author":"Nayak","year":"2010","journal-title":"Neuroscience"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/156652412803833599","article-title":"Molecular targets of FTY720 (fingolimod)","volume":"12","author":"Pitman","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1096\/fj.03-0910fje","article-title":"The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors","volume":"18","author":"Graler","year":"2004","journal-title":"FASEB J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1074\/jbc.M610318200","article-title":"Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor","volume":"282","author":"Oo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1038\/ncomms7416","article-title":"Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin","volume":"6","author":"Nussbaum","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40268-020-00316-1","article-title":"Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis","volume":"20","author":"Bascunana","year":"2020","journal-title":"Drugs R&D"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","article-title":"Fingolimod phosphate promotes the neuroprotective effects of microglia","volume":"256","author":"Noda","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-2094-8-76","article-title":"Fingolimod modulates microglial activation to augment markers of remyelination","volume":"8","author":"Jackson","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-015-0308-6","article-title":"FTY720 attenuates excitotoxicity and neuroinflammation","volume":"12","author":"Cipriani","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"118582","DOI":"10.1016\/j.lfs.2020.118582","article-title":"Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation","volume":"263","author":"Guo","year":"2020","journal-title":"Life Sci."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Gustin, A., Kirchmeyer, M., Koncina, E., Felten, P., Losciuto, S., Heurtaux, T., Tardivel, A., Heuschling, P., and Dostert, C. (2015). NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130624"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Sanna","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2020.00077","article-title":"Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson\u2019s Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model","volume":"11","author":"Pepin","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3389\/fimmu.2019.01241","article-title":"The Intra-nuclear SphK2-S1P Axis Facilitates M1-to-M2 Shift of Microglia via Suppressing HDAC1-Mediated KLF4 Deacetylation","volume":"10","author":"Ji","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.03.034","article-title":"FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing","volume":"119","author":"Das","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"24939","DOI":"10.1038\/srep24939","article-title":"Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer\u2019s disease","volume":"6","author":"Aytan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbi.2015.10.004","article-title":"Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia","volume":"52","author":"Serdar","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1523\/JNEUROSCI.2346-19.2020","article-title":"Fingolimod Rescues Demyelination in a Mouse Model of Krabbe\u2019s Disease","volume":"40","author":"Bechet","year":"2020","journal-title":"J. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.2174\/0929867326666190308133732","article-title":"FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment","volume":"27","author":"Wang","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1352458518805246","article-title":"Animal models of multiple sclerosis: From rodents to zebrafish","volume":"25","author":"Burrows","year":"2019","journal-title":"Mult. Scler."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bph.13476","article-title":"Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity","volume":"173","author":"Scott","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Musella, A., Gentile, A., Guadalupi, L., Rizzo, F.R., De Vito, F., Fresegna, D., Bruno, A., Dolcetti, E., Vanni, V., and Vitiello, L. (2020). Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis. Cells, 9.","DOI":"10.3390\/cells9051290"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Behrangi, N., Fischbach, F., and Kipp, M. (2019). Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action. Cells, 8.","DOI":"10.3390\/cells8010024"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ward, L.A., Lee, D.S., Sharma, A., Wang, A., Naouar, I., Ma, X.I., Pikor, N., Nuesslein-Hildesheim, B., Ramaglia, V., and Gommerman, J.L. (2020). Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury. JCI Insight., 5.","DOI":"10.1172\/jci.insight.132522"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nchembio.547","article-title":"Actions of a picomolar short-acting S1P(1) agonist in S1P(1)-eGFP knock-in mice","volume":"7","author":"Cahalan","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jns.2019.02.005","article-title":"RP001 hydrochloride improves neurological outcome after subarachnoid hemorrhage","volume":"399","author":"Li","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12031-014-0423-3","article-title":"Prominence of central sphingosine-1-phosphate receptor-1 in attenuating abeta-induced injury by fingolimod","volume":"54","author":"Kolahdooz","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1038\/s41598-019-47287-1","article-title":"Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Carreras","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/glia.22890","article-title":"Effect of Sema4D on microglial function in middle cerebral artery occlusion mice","volume":"63","author":"Sawano","year":"2015","journal-title":"Glia"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1038\/srep07279","article-title":"Bipolar\/rod-shaped microglia are proliferating microglia with distinct M1\/M2 phenotypes","volume":"4","author":"Tam","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Kartalou, G.I., Salgueiro-Pereira, A.R., Endres, T., Lesnikova, A., Casarotto, P., Pousinha, P., Delanoe, K., Edelmann, E., Castren, E., and Gottmann, K. (2020). Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238957"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s11481-017-9753-6","article-title":"FTY720 Attenuates Infection-Induced Enhancement of Abeta Accumulation in APP\/PS1 Mice by Modulating Astrocytic Activation","volume":"12","author":"McManus","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s11064-016-2125-4","article-title":"FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models","volume":"42","author":"Ren","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11481-019-09843-4","article-title":"FTY720 Inhibits MPP(+)-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation","volume":"14","author":"Yao","year":"2019","journal-title":"J. Neuroimmune Pharm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s12035-017-0468-8","article-title":"Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia","volume":"55","author":"Gaire","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Gaire, B.P., Bae, Y.J., and Choi, J.W. (2019). S1P1 Regulates M1\/M2 Polarization toward Brain Injury after Transient Focal Cerebral Ischemia. Biomol. Ther., 522\u2013529.","DOI":"10.4062\/biomolther.2019.005"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: Friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.5205-07.2008","article-title":"Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion","volume":"28","author":"Kunz","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Xie, W., Zhu, T., Dong, X., Nan, F., Meng, X., Zhou, P., Sun, G., and Sun, X. (2019). HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-kappaB signaling pathways. Biomolecules, 9.","DOI":"10.3390\/biom9100512"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/mol.111.076109","article-title":"S1P(1) receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis","volume":"81","author":"Cahalan","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/glia.23272","article-title":"Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination","volume":"66","author":"Kim","year":"2018","journal-title":"Glia"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1073\/pnas.1615413114","article-title":"Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation","volume":"114","author":"Rothhammer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1038\/s41598-021-86191-5","article-title":"Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis","volume":"11","author":"Oveland","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12974-016-0651-2","article-title":"Cuprizone demyelination induces a unique inflammatory response in the subventricular zone","volume":"13","author":"Hillis","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1038\/s41598-019-48609-z","article-title":"S1P2 contributes to microglial activation and M1 polarization following cerebral ischemia through ERK1\/2 and JNK","volume":"9","author":"Sapkota","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/ATVBAHA.107.143735","article-title":"Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN","volume":"27","author":"Sanchez","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"32841","DOI":"10.1074\/jbc.M305024200","article-title":"Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity","volume":"278","author":"Arikawa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1038\/ncomms8893","article-title":"Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke","volume":"6","author":"Kim","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/glia.23141","article-title":"Sphingosine-1-phosphate induces Ca(2+) signaling and CXCL1 release via TRPC6 channel in astrocytes","volume":"65","author":"Shirakawa","year":"2017","journal-title":"Glia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12974-015-0286-8","article-title":"Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and\/or 3","volume":"12","author":"Li","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.bbrc.2018.03.065","article-title":"S1P\/S1PR3 signaling mediated proliferation of pericytes via Ras\/pERK pathway and CAY10444 had beneficial effects on spinal cord injury","volume":"498","author":"Tang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-018-1323-1","article-title":"Sphingosine 1-phosphate receptor subtype 3 (S1P3) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization","volume":"15","author":"Gaire","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","article-title":"Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy","volume":"328","author":"Groves","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1096\/fj.02-0548com","article-title":"Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells","volume":"16","author":"Graeler","year":"2002","journal-title":"FASEB J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.201800221R","article-title":"Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity","volume":"33","author":"Fettel","year":"2019","journal-title":"FASEB J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1074\/jbc.M110.171819","article-title":"Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking","volume":"286","author":"Allende","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1038\/s41598-019-44845-5","article-title":"Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke","volume":"9","author":"Gallizioli","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1750-3639.2008.00182.x","article-title":"FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: Expression of central nervous system genes and reversal of blood-brain-barrier damage","volume":"19","author":"Foster","year":"2009","journal-title":"Brain Pathol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijdevneu.2003.09.003","article-title":"Microglial activation state and lysophospholipid acid receptor expression","volume":"21","author":"Tham","year":"2003","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.2353\/ajpath.2010.091234","article-title":"Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices","volume":"176","author":"Miron","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bbalip.2014.08.013","article-title":"Granule-mediated release of sphingosine-1-phosphate by activated platelets","volume":"1841","author":"Jonnalagadda","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fnins.2015.00140","article-title":"Activated platelets release sphingosine 1-phosphate and induce hypersensitivity to noxious heat stimuli in vivo","volume":"9","author":"Weth","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1471-4159.2004.02955.x","article-title":"Extracellular release of newly synthesized sphingosine-1-phosphate by cerebellar granule cells and astrocytes","volume":"92","author":"Anelli","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/glia.20324","article-title":"Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors","volume":"53","author":"Bassi","year":"2006","journal-title":"Glia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/stemcells.2006-0223","article-title":"Essential roles of sphingosine 1-phosphate\/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury","volume":"25","author":"Kimura","year":"2007","journal-title":"Stem. Cells"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Fischer, I., Alliod, C., Martinier, N., Newcombe, J., Brana, C., and Pouly, S. (2011). Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023905"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Sanada, Y., Mizushima, T., Kai, Y., Nishimura, J., Hagiya, H., Kurata, H., Mizuno, H., Uejima, E., and Ito, T. (2011). Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023933"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/17460441.2019.1646244","article-title":"Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis","volume":"14","author":"Volpi","year":"2019","journal-title":"Expert. Opin. Drug. Discov."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1124\/mol.64.5.1199","article-title":"Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes","volume":"64","author":"Sorensen","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0006-8993(03)03527-3","article-title":"Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes","volume":"990","author":"Rao","year":"2003","journal-title":"Brain Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijdevneu.2004.03.005","article-title":"Growth factor pre-treatment differentially regulates phosphoinositide turnover downstream of lysophospholipid receptor and metabotropic glutamate receptors in cultured rat cerebrocortical astrocytes","volume":"22","author":"Rao","year":"2004","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The Role of Astrocytes in CNS Inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte Crosstalk in CNS Inflammation","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2015.12.022","article-title":"Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis","volume":"361","author":"Farez","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Verzijl","year":"2010","journal-title":"Glia"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/nan.12048","article-title":"Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions","volume":"40","author":"Brana","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.22426","article-title":"Mechanisms of fingolimod\u2019s efficacy and adverse effects in multiple sclerosis","volume":"69","author":"Cohen","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-015-0297-0","article-title":"The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis","volume":"30","author":"Hunter","year":"2016","journal-title":"CNS Drugs"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biomaterials.2015.04.060","article-title":"Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis","volume":"62","author":"Wang","year":"2015","journal-title":"Biomaterials"},{"key":"ref_122","first-page":"121","article-title":"Central effects of fingolimod","volume":"59","author":"Cruz","year":"2014","journal-title":"Rev. Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"659206","DOI":"10.1155\/2014\/659206","article-title":"Chemokines and chemokine receptors in multiple sclerosis","volume":"2014","author":"Cheng","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2018.00217","article-title":"The Role of Astrocytes in Multiple Sclerosis","volume":"9","author":"Ponath","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1381612822666161214153108","article-title":"Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies","volume":"23","author":"Bjelobaba","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.24217","article-title":"Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide","volume":"76","author":"Colombo","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in Multiple Sclerosis: Therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"134599","DOI":"10.1016\/j.neulet.2019.134599","article-title":"Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis","volume":"715","author":"Ma","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.neuropharm.2006.11.010","article-title":"Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors","volume":"52","author":"Osinde","year":"2007","journal-title":"Neuropharmacology"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Lu, N., and Malemud, C.J. (2019). Extracellular Signal-Regulated Kinase: A Regulator of Cell Growth, Inflammation, Chondrocyte and Bone Cell Receptor-Mediated Gene Expression. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153792"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3892\/ijmm.2017.2962","article-title":"The extracellular signal-regulated kinase 1\/2 pathway in neurological diseases: A potential therapeutic target (Review)","volume":"39","author":"Sun","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12974-016-0690-8","article-title":"The crucial role of Erk2 in demyelinating inflammation in the central nervous system","volume":"13","author":"Okazaki","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fimmu.2020.00635","article-title":"Siponimod (BAF312) Activates Nrf2 While Hampering NFkappaB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration","volume":"11","author":"Colombo","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Vomund, S., Schafer, A., Parnham, M.J., Brune, B., and von Knethen, A. (2017). Nrf2, the Master Regulator of Anti-Oxidative Responses. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122772"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12974-016-0494-x","article-title":"The dual S1PR1\/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures","volume":"13","author":"Schubart","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.ajpath.2011.12.012","article-title":"FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms","volume":"180","author":"Norimatsu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-017-0882-x","article-title":"Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes","volume":"14","author":"Dusaban","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.2174\/0929867325666180514112124","article-title":"Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases","volume":"26","author":"Ferrer","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.3892\/mmr.2015.4120","article-title":"Effect of FTY720-phosphate on the expression of inflammation-associated molecules in astrocytes in vitro","volume":"12","author":"Janssen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jneuroim.2010.05.010","article-title":"The role of monocyte chemoattractant protein MCP1\/CCL2 in neuroinflammatory diseases","volume":"224","author":"Conductier","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"40518","DOI":"10.1038\/srep40518","article-title":"FcRgamma-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice","volume":"7","author":"Ogawa","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/hmg\/ddn126","article-title":"Sphingosine kinase 1\/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease","volume":"17","author":"Wu","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/s41467-018-05030-w","article-title":"Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases","volume":"9","author":"Gril","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1089\/ars.2017.7266","article-title":"Calcium Signaling Deficits in Glia and Autophagic Pathways Contributing to Neurodegenerative Disease","volume":"29","author":"Littlefield","year":"2018","journal-title":"Antioxid Redox Signal."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12974-018-1351-x","article-title":"Ca(2+)-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT\/mTOR signaling","volume":"15","author":"Yu","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ymthe.2016.12.008","article-title":"Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1476-5381.2011.01622.x","article-title":"Insights into the pharmacological relevance of lysophospholipid receptors","volume":"165","author":"Mutoh","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbamem.2017.03.008","article-title":"Sphingosine 1-phosphate\u2014A double edged sword in the brain","volume":"1859","author":"Karunakaran","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pmic.200900195","article-title":"Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture","volume":"10","author":"Bernhart","year":"2010","journal-title":"Proteomics"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1471-4159.2008.05599.x","article-title":"Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia","volume":"107","author":"Fujita","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12974-020-01809-1","article-title":"MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia","volume":"17","author":"Plastira","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-016-0701-9","article-title":"1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype","volume":"13","author":"Plastira","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuint.2008.11.004","article-title":"Profiling of BoNT\/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia","volume":"54","author":"Uchida","year":"2009","journal-title":"Neurochem. Int."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1471-4159.2010.06955.x","article-title":"Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain","volume":"115","author":"Ma","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pain.2005.02.009","article-title":"Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation","volume":"115","author":"Ledeboer","year":"2005","journal-title":"Pain"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1248\/bpb.34.1154","article-title":"Lysophosphatidic acid as the initiator of neuropathic pain","volume":"34","author":"Ueda","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/clp.10.88","article-title":"Lysophosphatidic acid as an initiator of neuropathic pain: Biosynthesis and demyelination","volume":"6","author":"Ueda","year":"2011","journal-title":"Clin. Lipidol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bbalip.2018.07.015","article-title":"Identifying lysophosphatidic acid receptor subtype 1 (LPA1) as a novel factor to modulate microglial activation and their TNF-alpha production by activating ERK1\/2","volume":"1863","author":"Kwon","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/jnc.15097","article-title":"Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA1 receptor","volume":"156","author":"Amaral","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Gaire, B.P., Sapkota, A., and Choi, J.W. (2020). BMS-986020, a Specific LPA1 Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice. Antioxidants, 9.","DOI":"10.3390\/antiox9111097"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Lee, C.H., Sapkota, A., Gaire, B.P., and Choi, J.W. (2020). NLRP3 Inflammasome Activation Is Involved in LPA1-Mediated Brain Injury after Transient Focal Cerebral Ischemia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228595"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-019-1555-8","article-title":"Lysophosphatidic acid receptor 1 (LPA1) plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia","volume":"16","author":"Gaire","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","article-title":"Lysophospholipid receptors in drug discovery","volume":"333","author":"Kihara","year":"2015","journal-title":"Exp. Cell. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/acs.oprd.7b00301","article-title":"Development of a Concise Multikilogram Synthesis of LPA-1 Antagonist BMS-986020 via a Tandem Borylation\u2013Suzuki Procedure","volume":"21","author":"Smith","year":"2017","journal-title":"Org. Process. Res. Dev."},{"key":"ref_165","first-page":"1207","article-title":"Autoradiographic evaluation of [18F]BMT-083133, a lysophosphatidic acid receptor 1 (LPA1) radioligand","volume":"55","author":"Pena","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbi.2020.09.032","article-title":"Inhibition of lysophosphatidic acid receptor 1 attenuates neuroinflammation via PGE2\/EP2\/NOX2 signalling and improves the outcome of intracerebral haemorrhage in mice","volume":"91","author":"Gao","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1476-5381.2010.00828.x","article-title":"A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model","volume":"160","author":"Swaney","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1124\/jpet.110.175901","article-title":"Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist","volume":"336","author":"Swaney","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1096\/fj.202000317R","article-title":"Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain","volume":"34","author":"Rivera","year":"2020","journal-title":"FASEB J."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/pmt-2019-0036","article-title":"LPA receptor signaling as a therapeutic target for radical treatment of neuropathic pain and fibromyalgia","volume":"10","author":"Ueda","year":"2020","journal-title":"Pain Manag."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neuropharm.2019.05.027","article-title":"Modulation of LPA1 receptor-mediated neuronal apoptosis by Saikosaponin-d: A target involved in depression","volume":"155","author":"Xu","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"106181","DOI":"10.1016\/j.intimp.2019.106181","article-title":"Saikosaponin-d attenuated lipopolysaccharide-induced depressive-like behaviors via inhibiting microglia activation and neuroinflammation","volume":"80","author":"Su","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbi.2018.12.007","article-title":"Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice","volume":"76","author":"Chun","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_174","first-page":"776","article-title":"Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors","volume":"60","author":"Fischer","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.64.4.994","article-title":"Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors","volume":"64","author":"Ohta","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.freeradbiomed.2011.11.014","article-title":"Autotaxin protects microglial cells against oxidative stress","volume":"52","author":"Awada","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/cbic.201500559","article-title":"Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5","volume":"17","author":"Kozian","year":"2016","journal-title":"Chembiochem"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1016\/j.bmcl.2012.06.057","article-title":"Selective non-lipid modulator of LPA5 activity in human platelets","volume":"22","author":"Kozian","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Sapkota, A., Lee, C.H., Park, S.J., and Choi, J.W. (2020). Lysophosphatidic Acid Receptor 5 Plays a Pathogenic Role in Brain Damage after Focal Cerebral Ischemia by Modulating Neuroinflammatory Responses. Cells, 9.","DOI":"10.3390\/cells9061446"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fncel.2019.00531","article-title":"Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells","volume":"13","author":"Plastira","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12974-017-1024-1","article-title":"Lysophosphatidic acid via LPA-receptor 5\/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype","volume":"14","author":"Plastira","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4062\/biomolther.2020.159","article-title":"Inhibition of LPA5 Activity Provides Long-Term Neuroprotection in Mice with Brain Ischemic Stroke","volume":"28","author":"Sapkota","year":"2020","journal-title":"Biomol. Ther."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvq052","article-title":"Autotaxin\u2014an LPA producing enzyme with diverse functions","volume":"148","author":"Nakanaga","year":"2010","journal-title":"J. Biochem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-007-9480-6","article-title":"Autotaxin: A secreted autocrine\/paracrine factor that promotes glioma invasion","volume":"86","author":"Hoelzinger","year":"2008","journal-title":"J. Neurooncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/excr.1998.4224","article-title":"Regulation of astrocyte morphology by RhoA and lysophosphatidic acid","volume":"245","author":"Ramakers","year":"1998","journal-title":"Exp. Cell Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1083\/jcb.109.5.2495","article-title":"Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors","volume":"109","author":"Defize","year":"1989","journal-title":"J. Cell Biol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1038\/srep07847","article-title":"Astrocytes increase ATP exocytosis mediated calcium signaling in response to microgroove structures","volume":"5","author":"Singh","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/glia.20284","article-title":"Role of intracellular S100A4 for migration of rat astrocytes","volume":"53","author":"Takenaga","year":"2006","journal-title":"Glia"},{"key":"ref_189","first-page":"1546","article-title":"Connexins in Astrocyte Migration","volume":"10","author":"Avalos","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"39139","DOI":"10.1074\/jbc.M403439200","article-title":"Aggregation of integrins and RhoA activation are required for Thy-1-induced morphological changes in astrocytes","volume":"279","author":"Avalos","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: Biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.tins.2009.08.002","article-title":"Molecular dissection of reactive astrogliosis and glial scar formation","volume":"32","author":"Sofroniew","year":"2009","journal-title":"Trends Neurosci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00441-010-0977-5","article-title":"LPA receptor expression in the central nervous system in health and following injury","volume":"341","author":"Goldshmit","year":"2010","journal-title":"Cell Tissue Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/glia.10054","article-title":"Immunohistological localization of the myelinating cell-specific receptor LP(A1)","volume":"38","author":"Cervera","year":"2002","journal-title":"Glia"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neuint.2007.07.004","article-title":"Lysophosphatidic acid stimulates astrocyte proliferation through LPA1","volume":"52","author":"Shano","year":"2008","journal-title":"Neurochem. Int."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1471-4159.2011.07188.x","article-title":"Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1beta-induced attenuation of Rho signaling pathways in rat astrocytes","volume":"117","author":"Sato","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/jpet.116.236455","article-title":"LPA1 Mediates Antidepressant-Induced ERK1\/2 Signaling and Protection from Oxidative Stress in Glial Cells","volume":"359","author":"Olianas","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1097\/j.pain.0000000000001316","article-title":"Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain","volume":"159","author":"Ueda","year":"2018","journal-title":"Pain"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1074\/jbc.M707758200","article-title":"Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation","volume":"283","author":"Spohr","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Sapkota, A., Park, S.J., and Choi, J.W. (2021). Receptor for Advanced Glycation End Products Is Involved in LPA5-Mediated Brain Damage after a Transient Ischemic Stroke. Life, 11.","DOI":"10.3390\/life11020080"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/15\/7864\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:33:48Z","timestamp":1760164428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/15\/7864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":200,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22157864"],"URL":"https:\/\/doi.org\/10.3390\/ijms22157864","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]}}}